Navigation Links
Positive FDA Meeting Confirms BDSI Phase 3 Program for Clonidine Topical Gel for Treatment of Painful Diabetic Neuropathy
Date:12/2/2013

RALEIGH, N.C., Dec. 2, 2013 /PRNewswire/ -- BioDelivery Sciences International, Inc. (Nasdaq: BDSI) announced that it engaged in a positive meeting with the U.S. Food and Drug Administration (FDA) regarding the clinical development program for Clonidine Topical Gel that will allow the program to proceed to Phase 3 clinical studies in the first quarter of 2014.

(Logo:  http://photos.prnewswire.com/prnh/20110217/CL49801LOGO )

BDSI met with representatives of the FDA on November 21, 2013 to discuss the proposed clinical development program for Clonidine Topical Gel for the treatment of painful diabetic neuropathy (PDN).  The FDA agreed with the overall clinical program proposed by BDSI which included two placebo-controlled studies and one safety study in patients suffering from painful diabetic neuropathy, the duration of treatment required for the safety assessment, and the plan for data integration from prior and planned clinical studies.   

"As we continue our work to expand and diversify our product pipeline, we are very pleased with the outcome of our discussion with FDA regarding the development program for Clonidine Topical Gel," said Dr. Andrew Finn, Executive Vice President of Product Development.  "The discussion has provided us with the input and clarity needed to progress the program directly to Phase 3, and we will initiate the first of two pivotal studies in early 2014.  It also appears that the FDA recognizes the need for new treatment options for painful diabetic neuropathy by confirming Fast Track designation for the program that could potentially lead to a priority review."     

The feedback from FDA enables BDSI to initiate the first of two placebo controlled stud
'/>"/>

SOURCE BioDelivery Sciences International, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Positive Opinion, Stock Price Movement, and Executive Appointments - Research Report on Celgene, Sirona, Centene, Fresenius Medical Care, and PerkinElmer
2. According to Surveyed U.S. Oncologists, Zelboraf is the Patient Share Leader in First-Line BRAF-Mutation Positive Malignant Melanoma
3. BioLineRx Announces New Positive Results in Phase 2a trial for Orally Available Inflammatory Bowel Disease Treatment
4. Sanofi and Regeneron Report Positive Results with Sarilumab in First Phase 3 Rheumatoid Arthritis Registration Trial
5. BioLineRx Reports Publication in Peer Review Journal of Positive Phase 1/2 Results in Stem Cell Mobilization for Multiple Myeloma
6. Isis Pharmaceuticals Reports Fifth Positive Phase 2 Data Set for ISIS-APOCIII Rx Showing Significant Reductions in Triglyceride and ApoC-III Levels
7. Lumena Pharmaceuticals Receives Positive Opinion for Orphan Drug Designation in the European Union for LUM001 in Four Rare Liver Diseases
8. Isis Pharmaceuticals Reports Positive Phase 1 Data Demonstrating ISIS-APO(a) Rx Produces Significant Reductions in Lp(a) Levels
9. American Journal of Obstetrics & Gynecology Publishes New Clinical Study Showing Positive Performance of Vermillions OVA1 Test in Presurgical Detection of Early-Stage Ovarian Cancer
10. American Journal of Obstetrics & Gynecology Publishes New Clinical Study Showing Positive Performance of Vermillions Ovarian Cancer Test, OVA1
11. Regulus Presents Positive Preclinical Data Demonstrating that microRNA-21 Plays an Important Role in Alport Syndrome
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... Mar. 04, 2015 Research and Markets ... of the "Negative Pressure Wound Therapy Market ... Industry Analysis, Size, Share, Growth, Trends and Forecast ... , The global negative pressure ... and by geography. By product types the NPWT ...
(Date:3/4/2015)... 4, 2015  ECR Booth #317/Expo C - Varian ... a full spectrum of X-ray imaging solutions that bundle ... and enable greater patient throughput for manufacturers of mammography, ... solutions are on display at the Annual European Congress ... this week.   "This year,s ...
(Date:3/4/2015)... 2015  Imprimis Pharmaceuticals, Inc. (NASDAQ: IMMY ... commercialization of proprietary compounded drug therapies, today reported that ... 2014 financial results on Thursday, March 12, 2015.  The ... EDT (1:30 p.m. PDT) on the same day to ... activities.  The conference call and webcast will be open ...
Breaking Medicine Technology:Global Negative Pressure Wound Therapy (Conventional and Single Use NPWT Systems) Market Report 2014-2020 2Varian Medical Systems to Showcase New X-Ray Imaging Components at the European Congress of Radiology (ECR) Annual Meeting 2Varian Medical Systems to Showcase New X-Ray Imaging Components at the European Congress of Radiology (ECR) Annual Meeting 3Imprimis Pharmaceuticals to Host its Fourth Quarter and Fiscal Year 2014 Financial Report Conference Call and Webcast on March 12, 2015 at 4:30 p.m. EDT 2Imprimis Pharmaceuticals to Host its Fourth Quarter and Fiscal Year 2014 Financial Report Conference Call and Webcast on March 12, 2015 at 4:30 p.m. EDT 3
... 6, 2011 Actavis, an international generic pharmaceuticals ... approval from the US Food & Drug Administration ... mg CIV.  Distribution of the product has commenced. ... to launch Zolpidem Tartrate Extended-Release Tablets 6.25 mg strength ...
... June 6, 2011 Brainlab announced today ... acquire Voyant Health. Voyant Health,s core technology, ... and to plan and digitally template surgical procedures from ... the operating room (OR). Another key technology is VoyantLink™, ...
Cached Medicine Technology:Actavis Receives FDA Approval of Zolpidem Tartrate Extended-Release Tablets USP, 12.5 mg CIV in the U.S. 2Brainlab Acquires Voyant Health 2Brainlab Acquires Voyant Health 3
(Date:3/4/2015)... 2015 The Global Liquefied Petroleum ... 2014 and is estimated to grow to $288.7 ... from 2014 to 2019. , Browse through the ... an analysis of industry trends, segments & forecasts., ... petroleum gas market is classified into source, application, ...
(Date:3/4/2015)... 04, 2015 Organic Valley, the nation’s largest ... announced its cause campaign to Save the Bros, http://savethebros.com/ ... making a difference to Bros everywhere. To date, the ... Facebook. The video was named Adweek’s best commercial of ... Mashable and Digiday, among other media outlets. , “We ...
(Date:3/4/2015)... Columbus is no stranger to drug addiction. The ... addiction, and suffers from the potential threat of Kratom. In ... DEA revealed that Kratom is a “drug of concern.” Although ... introduced herb from Southeast Asia acts as a stimulant in ... kratom foments symptoms similar to heroin withdrawal, and includes tremors, ...
(Date:3/4/2015)... 04, 2015 Plungerhead has ... service members during and after their service to the ... increase awareness through advertising, social media and several national ... patriotic organization through a special retail promotion of Plungerhead ... March through May 2015. , “There is a ...
(Date:3/4/2015)... Port Richey, FL (PRWEB) March 04, 2015 ... Medical Detox cut the ribbon on their new facility in ... Pasco Chamber of Commerce. The new facility will allow the ... of helping end the prescription drug abuse epidemic through treatment ... current reality of drug addiction in the United States, we ...
Breaking Medicine News(10 mins):Health News:The Global Liquefied Petroleum Gas Market is Estimated to Reach $288.7 Billion by 2019 - A Report by MicroMarket Monitor 2Health News:The Global Liquefied Petroleum Gas Market is Estimated to Reach $288.7 Billion by 2019 - A Report by MicroMarket Monitor 3Health News:ORGANIC VALLEY URGES PUBLIC TO SAVE THE BROs: CAMPAIGN EARNS MORE THAN 1M VIEWS ON YOUTUBE 2Health News:ORGANIC VALLEY URGES PUBLIC TO SAVE THE BROs: CAMPAIGN EARNS MORE THAN 1M VIEWS ON YOUTUBE 3Health News:Columbus, OH Combats the Sale of Kratom as a Drug, Harbor Village Detox Stresses Caution 2Health News:Plungerhead Partners with the Boot Campaign to Benefit US Military Community 2Health News:Plungerhead Partners with the Boot Campaign to Benefit US Military Community 3Health News:Novus Medical Detox Hosts Ribbon Cutting Ceremony at Pasco County Facility 2Health News:Novus Medical Detox Hosts Ribbon Cutting Ceremony at Pasco County Facility 3
... the road, fewer older drivers died in crashes and fewer ... past, a new Insurance Institute for Highway Safety study reports. ... during the period, reversing an upward trend, even as the ... with drivers ages 35-54, older drivers experienced much bigger declines ...
... and the press to be held at 6:00 p.m. ... in Washington, DC "An informative must-read for anyone ... level by better serving employees and saving money." Adam ... Sreedhar Potarazu, M.D., M.B.A., has worked as an industry ...
... rate of chronic disease that often goes untreated , , ... Americans currently being held in correctional facilities across the ... chronic illness than the general population does, a new ... about 1 percent of the total U.S. population -- ...
... Because" Online Contest Asks Pet Owners to Explain Why They ... love our pets? A new online promotion, "I Love My ... the opportunity to tell the world why they love their ... to a group of service dogs that are specially trained ...
... The US neuropathic pain market consists of 4.7 ... more than 6.1 million patients, and be valued ... )David B. Phillips, Ph.D. reports "We have not ... businesses because our market is growing."John Johnson, Marketing ...
... Rather Than Their OwnSACRAMENTO, Calif., Jan. 16 With ... Week (Jan. 17 - Jan. 23) by the U.S. ... monitors than usual on California ski slopes. These ... Luther King holiday weekend to remind visitors to watch ...
Cached Medicine News:Health News:Contrary to Earlier Predictions, Older Driver Fatal Crashes Trend Down 2Health News:Contrary to Earlier Predictions, Older Driver Fatal Crashes Trend Down 3Health News:National Tour Begins to Promote Book and Discuss Key Issues Impacting the U.S. Workforce...and How the Obama Administration Can Prevent the Next Economic Catastrophe 2Health News:Many in U.S. Prisons Lack Good Health Care 2Health News:Many in U.S. Prisons Lack Good Health Care 3Health News:New Vectra 3D(TM) Promotion Benefits New Horizons Service Dogs 2Health News:New Vectra 3D(TM) Promotion Benefits New Horizons Service Dogs 3Health News:ReBuilder Medical (RBRM) Neuropathy Market Doubles to $5 Billion 2Health News:Ski Resorts Celebrate National Safety Awareness Week While Keeping Patrons in the Dark About Safety Plans 2Health News:Ski Resorts Celebrate National Safety Awareness Week While Keeping Patrons in the Dark About Safety Plans 3
... four channel platelet aggregation profiler combined with ... conjunction with Microsoft WindowsTM, the PAP-4CD has ... automatic storage of test results, plus simplified ... modes are available: chromogenic assays, von willebrand ...
... 400 plus, innovation means 4 on-board ... cuvettes and im-proved operator ergonomics. This ... ease-of-use required for true workload consolidation, ... with only one analytical platform, one ...
... The Advia 2400 ... sample volume (as low ... water consumption (40 L/hour) ... The optional universal rack ...
Iron FS Ferene for determination of iron in serum. Available with Calibrator: Trucal U and Controls: Trulab N, Trulab P. For automated systems....
Medicine Products: